Guadecitabine plus ipilimumab in unresectable melanoma: five-year follow-up and correlation with integrated, multiomic analysis in the NIBIT-M4 trial
暂无分享，去创建一个
T. Noviello | C. Sautès-Fridman | G. Pruneri | D. Bedognetti | W. Fridman | M. Maio | A. Anichini | R. Mortarini | A. Covre | S. Coral | E. Simonetti | F. Caruso | M. F. Lofiego | S. Brich | A. D. Di Giacomo | M. Costa | M. Ceccarelli | G. Scala | T. Noviello | F. Caruso | M. F. Logiego | EPigenetic Immune-oncology Consortium Airc investigators | A. M. Giacomo | Wolf H Fridman | Maria Claudia Costa | Michele Maio | Michele Ceccarelli | Davide Bedognetti | Teresa Maria | Rosaria Noviello | Giovanni Scala | Giancarlo Pruneri | Elena Simonetti | W. Fridman